<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00291174</url>
  </required_header>
  <id_info>
    <org_study_id>803272</org_study_id>
    <nct_id>NCT00291174</nct_id>
  </id_info>
  <brief_title>Measuring Electrical Resistance of Different Tissues on the Outer Surface of the Heart</brief_title>
  <official_title>Impedance Measurement of Epicardial Substrate for Ventricular Arrhythmias: Case Control Series of Patients With and Without Myocardial Scarring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biosense Webster, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <brief_summary>
    <textblock>
      This is a research study to evaluate the electrical properties of heart tissue. The purpose
      of this study is to determine the impedance (electrical resistance) of different tissues on
      the outer surface of the heart. This may be important for distinguishing scarred heart muscle
      from fat that can be seen on the surface of the heart. This information may eventually be
      utilized in patients that undergo a procedure (called catheter ablation) for the treatment of
      life-threatening heart rhythms. Investigators expect a detectable difference between the
      impedance of normal and infarcted myocardium (approximately 50 ohms).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The treatment of cardiac arrhythmias with endocardial catheter ablation has evolved rapidly
      over the past few decades. At the time of this writing, the ablation of almost all atrial and
      ventricular arrhythmias has been described in the literature. Multiple energy modalities
      (e.g. radiofrequency, cryotherapy) and approaches (e.g. retrograde aortic, transseptal
      puncture) have been described, yet ablation of some rhythms is not as successful as others.

      The realization that ventricular tachycardia (VT) in the setting of Chagas Disease can
      originate in the epicardium has lead to the development of a percutaneous, transthoracic
      epicardial approach to mapping and ablation of this arrhythmia. This approach has now been
      applied to patients with VT in the setting of ischemic and nonischemic heart disease at many
      centers throughout the world. Traditional mapping technologies are utilized on the epicardium
      to define scarred heart tissue and locate the VT circuit.

      It is well known that human hearts display a variable amount of fat overlying the epicardium.
      Not only is the coronary vasculature embedded in a layer of adipose tissue, but the rest of
      the heart may have areas of epicardial fat. As fat is an insulator and does not generate or
      easily conduct electrical activity, current mapping techniques may classify epicardial fat
      incorrectly as myocardial scar. This may have important effects on the ability to diagnose
      and treat arrhythmias with epicardial ablation.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unforeseen difficulty identifying and enrolling eligible subjects
  </why_stopped>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">July 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">8</enrollment>
  <condition>Cardiomyopathies</condition>
  <condition>Ventricular Dysfunction</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Arrhythmia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing elective cardiac surgery for coronary artery disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients undergoing elective cardiac surgery for coronary artery disease
             (with or without normal heart function) or valvular disease (with normal heart
             function) at the Hospital of the University of Pennsylvania under the direction of Y.
             Joseph Woo MD will be eligible.

        Exclusion Criteria:

          -  Patients undergoing emergent surgery and patients with idiopathic cardiomyopathy,
             infiltrative cardiomyopathies and hypertrophic cardiomyopathies will be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J. Callans, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania, Dept of Medicine, Cardiology Division</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sosa E, Scanavacca M, d'Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996 Jun;7(6):531-6.</citation>
    <PMID>8743758</PMID>
  </reference>
  <reference>
    <citation>Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004 May 19;43(10):1834-42.</citation>
    <PMID>15145109</PMID>
  </reference>
  <reference>
    <citation>Dixit S, Narula N, Callans DJ, Marchlinski FE. Electroanatomic mapping of human heart: epicardial fat can mimic scar. J Cardiovasc Electrophysiol. 2003 Oct;14(10):1128.</citation>
    <PMID>14521672</PMID>
  </reference>
  <reference>
    <citation>Zarowitz BJ, Pilla AM. Bioelectrical impedance in clinical practice. DICP. 1989 Jul-Aug;23(7-8):548-55. Review.</citation>
    <PMID>2669371</PMID>
  </reference>
  <reference>
    <citation>Casas O, Bragós R, Riu PJ, Rosell J, Tresànchez M, Warren M, Rodriguez-Sinovas A, Carreño A, Cinca J. In vivo and in situ ischemic tissue characterization using electrical impedance spectroscopy. Ann N Y Acad Sci. 1999 Apr 20;873:51-8.</citation>
    <PMID>10372149</PMID>
  </reference>
  <reference>
    <citation>Cinca J, Warren M, Carreño A, Tresànchez M, Armadans L, Gómez P, Soler-Soler J. Changes in myocardial electrical impedance induced by coronary artery occlusion in pigs with and without preconditioning: correlation with local ST-segment potential and ventricular arrhythmias. Circulation. 1997 Nov 4;96(9):3079-86.</citation>
    <PMID>9386178</PMID>
  </reference>
  <reference>
    <citation>Cinca J, Warren M, Rodríguez-Sinovas A, Tresànchez M, Carreño A, Bragós R, Casas O, Domingo A, Soler-Soler J. Passive transmission of ischemic ST segment changes in low electrical resistance myocardial infarct scar in the pig. Cardiovasc Res. 1998 Oct;40(1):103-12.</citation>
    <PMID>9876322</PMID>
  </reference>
  <reference>
    <citation>Ellenby MI, Small KW, Wells RM, Hoyt DJ, Lowe JE. On-line detection of reversible myocardial ischemic injury by measurement of myocardial electrical impedance. Ann Thorac Surg. 1987 Dec;44(6):587-97.</citation>
    <PMID>3689045</PMID>
  </reference>
  <reference>
    <citation>Fallert MA, Mirotznik MS, Downing SW, Savage EB, Foster KR, Josephson ME, Bogen DK. Myocardial electrical impedance mapping of ischemic sheep hearts and healing aneurysms. Circulation. 1993 Jan;87(1):199-207.</citation>
    <PMID>8419008</PMID>
  </reference>
  <reference>
    <citation>Kléber AG, Riegger CB, Janse MJ. Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ Res. 1987 Aug;61(2):271-9.</citation>
    <PMID>3621491</PMID>
  </reference>
  <reference>
    <citation>Salazar Y, Bragos R, Casas O, Cinca J, Rosell J. Transmural versus nontransmural in situ electrical impedance spectrum for healthy, ischemic, and healed myocardium. IEEE Trans Biomed Eng. 2004 Aug;51(8):1421-7.</citation>
    <PMID>15311828</PMID>
  </reference>
  <reference>
    <citation>Salazar Y, Cinca J, Rosell-Ferrer J. Effect of electrode locations and respiration in the characterization of myocardial tissue using a transcatheter impedance method. Physiol Meas. 2004 Oct;25(5):1095-103.</citation>
    <PMID>15535176</PMID>
  </reference>
  <reference>
    <citation>Schwartzman D, Chang I, Michele JJ, Mirotznik MS, Foster KR. Electrical impedance properties of normal and chronically infarcted left ventricular myocardium. J Interv Card Electrophysiol. 1999 Oct;3(3):213-24.</citation>
    <PMID>10490477</PMID>
  </reference>
  <reference>
    <citation>Warren M, Bragós R, Casas O, Rodríguez-Sinovas A, Rosell J, Anivarro I, Cinca J. Percutaneous electrocatheter technique for on-line detection of healed transmural myocardial infarction. Pacing Clin Electrophysiol. 2000 Aug;23(8):1283-7.</citation>
    <PMID>10962753</PMID>
  </reference>
  <reference>
    <citation>Wolf T, Gepstein L, Hayam G, Zaretzky A, Shofty R, Kirshenbaum D, Uretzky G, Oron U, Ben-Haim SA. Three-dimensional endocardial impedance mapping: a new approach for myocardial infarction assessment. Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H179-88.</citation>
    <PMID>11123232</PMID>
  </reference>
  <reference>
    <citation>Wolf T, Gepstein L, Dror U, Hayam G, Shofti R, Zaretzky A, Uretzky G, Oron U, Ben-Haim SA. Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol. 2001 May;37(6):1590-7.</citation>
    <PMID>11345370</PMID>
  </reference>
  <reference>
    <citation>Zhu F, Leonard EF, Levin NW. Body composition modeling in the calf using an equivalent circuit model of multi-frequency bioimpedance analysis. Physiol Meas. 2005 Apr;26(2):S133-43. Epub 2005 Mar 29.</citation>
    <PMID>15798226</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2006</study_first_submitted>
  <study_first_submitted_qc>February 10, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2006</study_first_posted>
  <last_update_submitted>August 15, 2016</last_update_submitted>
  <last_update_submitted_qc>August 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ventricular Arrhythmia</keyword>
  <keyword>Myocardial Infarction</keyword>
  <keyword>Ventricular Dysfunction</keyword>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Structural Heart Disease</keyword>
  <keyword>Arrhythmia</keyword>
  <keyword>Cardiomyopathies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

